The EU has been a donor to Gavi since 2003 with increasing financial and political support. Building up immunisation systems is a fundamental part of the work the EU does with Gavi and partner countries to strengthen health systems.

The European Commission has taken an active role in Gavi and in May 2014 held an event to launch Gavi’s second replenishment and increased its contribution to EUR 175 million for the period 2016-2020. This commitment was increased to a total of EUR 200 million at the replenishment conference in Berlin the following year.  This marked a substantial (threefold) increase from the previous financing period. The contribution comprised EUR 70 million from the Development Co-operation Instrument (DCI) and EUR 130 million from the intra-ACP envelope of the European Development Fund (EDF). The European Commission contributed USD 58 million between 2003 and 2010. At Gavi’s pledging conference in June 2011, the EU committed an additional EUR 10 million to Gavi from the DCI and EDF financing instruments.

On 4 June 2020, at the Global Vaccine Summit, President von der Leyen pledged EUR 300 million to Gavi for the 2021-2025 period, marking a 50% increase in the Commission’s commitment compared to the previous period.

In 2020 the EU committed support to the COVAX Facility, with a EUR 400 million EU guaranteed loan provided through the European Investment Bank, as part of its Global Coronavirus Response. The European Commission President then announced a contribution of an additional EUR 100 million EUR in grant funding from the EU, to support the COVAX Facility to secure access to the future COVID-19 vaccine in low and middle-income countries.

Contributions and pledges in total:

  • Direct funding
    • (2000-2010): EUR 41 million (USD 58 million)
    • (2011-2015): EUR 29 million (USD 35 million)
    • (2016-2020) EUR 210 million (USD 242 million)
    • (2021-2025): EUR 300 million (USD 351 million)
  • COVAX AMC (2021): EUR 100 million (USD 117 million)

EU guaranteed loan through the European Investment Bank:

  • COVAX Facility (2021): EUR 400 million (USD 468 million)


Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.

Contributions and pledges over time (US$ Millions)

Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data

Direct Contributions (including Matching Fund)

Received contributions: non-US$ contributions for 2000-2019 and Q1-Q3 2020 are expressed in US$ equivalents using the exchange rates on the dates of receipt.  For 2014-2019 and Q1-Q3 2020 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

Future contributions (for pledges made prior to the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020.

Future contributions (for pledges at the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020 and years

IFFIm contributions

Future contributions:  non-US$ contributions for Q4-2020 and for years 2021 and beyond are expressed in US$ equivalents as follows:

Where the contribution agreement has been signed:  contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed:  contributions are expressed in US$ equivalents using the applicable spot rates from Bloomberg as at 30 September 2020

Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.

While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2020, IFFIm donor grant payments are reduced by 0.5%, however such reductions are not reflected in future contributions figures.

All donors

Subscribe to our newsletter